|
Index of reports
> All cases (100)
Below is the selection of adverse event reports related to Zantac (Ranitidine) that includes all cases.
Reports 1 - 25 of 100 Next >>
Adverse event in male receiving Zantac (Ranitidine)
Reported by a physician from Japan on 2007-10-30
Patient: male
Adverse reactions / side effects: Interstitial Lung Disease, Respiratory Failure, Lung Abscess
Adverse event resulted in: death
Suspect drug(s):
Finibax
Finibax
Indication: Lung Abscess
Norvasc
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Itraconazole
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Zantac
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Ferromia
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Erythrocin
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Biofermin R
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Sucralfate
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Slow-K
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Mucosta
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Juzen-Taiho-TO
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Cravit
Adverse event in receiving Zantac (Ranitidine)
Reported by a pharmacist from United Kingdom on 2007-10-25
Patient:
Adverse reactions / side effects: Macular Degeneration
Suspect drug(s):
Zantac (Ranitidine)
Adverse event in male receiving Zantac (Ranitidine)
Reported by a physician from Japan on 2007-10-19
Patient: male
Adverse reactions / side effects: Interstitial Lung Disease, Lung Abscess
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Finibax
Finibax
Indication: Lung Abscess
Norvasc
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Itraconazole
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Zantac
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Ferromia
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Erythrocin Lactobionate
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Biofermin R
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Sucralfate
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Slow-K
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Mucosta
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Juzen-Taiho-TO
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Levofloxacin
Adverse event in 2 month old male receiving Zantac (Ranitidine)
Reported by a consumer/non-health professional from United States on 2007-10-17
Patient: 2 month old male, weighing 5.4 kg (11.9 pounds)
Adverse reactions / side effects: Drug Exposure VIA Breast Milk, Erythema Multiforme
Suspect drug(s):
Zantac (Ranitidine)
Adverse event in 77 year old male receiving Zantac (Ranitidine)
Reported by a pharmacist from Japan on 2007-10-05
Patient: 77 year old male
Adverse reactions / side effects: Agranulocytosis
Adverse event resulted in: hospitalization
Suspect drug(s):
Aspirin
Dosage: total daily dose: 100 mg unit dose: 100 mg
Administration route: Oral
End date: 2007-06-11
Zantac
Dosage: total daily dose: 150 mg unit dose: 150 mg
Administration route: Oral
End date: 2007-06-11
Lipitor
Dosage: total daily dose: 10 mg unit dose: 10 mg
Administration route: Oral
End date: 2007-06-11
Tenormin
Dosage: total daily dose: 50 mg unit dose: 50 mg
Administration route: Oral
End date: 2007-06-11
Pletal
Administration route: Oral
End date: 2007-06-11
Bepricor
Administration route: Oral
End date: 2007-06-11
Sigmart
Administration route: Oral
End date: 2007-06-11
Lendormin
Administration route: Oral
Indication: Insomnia
End date: 2007-06-11
Warfarin Potassium
Administration route: Oral
End date: 2007-06-11
Other drugs received by patient: Lasix; Mucosolvan
Adverse event in 65 year old female receiving Zantac (Ranitidine)
Reported by a physician from Japan on 2007-10-05
Patient: 65 year old female
Adverse reactions / side effects: Cardio-Respiratory Arrest, Vomiting, Cyanosis, Angiopathy, Pallor, Cough, Shock
Adverse event resulted in: life threatening event
Suspect drug(s):
Zantac
Dosage: 50mg per day
Indication: Fallopian Tube Cancer
Start date: 2006-12-07
End date: 2007-04-05
Kytril
Dosage: 3mg per day
Indication: Fallopian Tube Cancer
Start date: 2006-12-07
End date: 2007-04-05
Other drugs received by patient: Decadron; Vena; Sodium Chloride 0.9%; Veen-D; Bosmin
Adverse event in 66 year old female receiving Zantac (Ranitidine)
Reported by a physician from Japan on 2007-10-02
Patient: 66 year old female, weighing 58.0 kg (127.6 pounds)
Adverse reactions / side effects: Aplastic Anaemia, Bone Marrow Failure
Adverse event resulted in: hospitalization
Suspect drug(s):
Prograf
Dosage: 3 mg, /d, oral
Administration route: Oral
Indication: Interstitial Lung Disease
Start date: 2006-08-01
End date: 2007-07-13
Zantac
End date: 2007-07-13
Other drugs received by patient: Predonide (Prednisolone); Baktar (Sulfamethoxazole, Trimethoprim); Bonalon (Alendronic Acid); Panaldine (Ticlopidine Hydrochloride); Crestor
Adverse event in 43 year old male receiving Zantac (Ranitidine)
Reported by a pharmacist from United States on 2007-07-24
Patient: 43 year old male
Adverse reactions / side effects: Liver Function Test Abnormal
Adverse event resulted in: hospitalization
Suspect drug(s):
Zantac (Ranitidine)
Other drugs received by patient: Multi-Vitamin; Zofran; Promethazine; Insulin; Tylenol (Caplet); Risperidone; Oxycodone HCL; Colace; Heparin; Morphine
Adverse event in 45 year old male receiving Zantac (Ranitidine)
Reported by a pharmacist from United Kingdom on 2007-07-19
Patient: 45 year old male
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Rhabdomyolysis
Adverse event resulted in: hospitalization
Suspect drug(s):
Floxapen
Indication: Drug USE FOR Unknown Indication
Zantac
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Hydrocortisone; Ciprofloxacin
Adverse event in 59 year old female receiving Zantac (Ranitidine)
Reported by a individual with unspecified qualification from United States on 2007-07-13
Patient: 59 year old female
Adverse reactions / side effects: Intraocular Pressure Increased, Gastric Ulcer
Suspect drug(s):
Boniva
Dosage: 150 mg oral
Administration route: Oral
Indication: Osteoporosis Postmenopausal
Start date: 2006-08-15
End date: 2007-02-15
Zantac
Other drugs received by patient: Xanax; Tums (Calcium Carbonate); Protonix
Adverse event in 64 year old female receiving Zantac (Ranitidine)
Reported by a physician from Japan on 2007-07-12
Patient: 64 year old female
Adverse reactions / side effects: C-Reactive Protein Increased, Pancytopenia, Pyrexia
Adverse event resulted in: hospitalization
Suspect drug(s):
Zantac (Ranitidine)
Other drugs received by patient: Omepral; Ciprofloxacin; Prodif; Vancomycin HCL; Vancomycin HCL; Maxipime; Gran; Predonine; Predonine
Adverse event in 12 year old female receiving Zantac (Ranitidine)
Reported by a consumer/non-health professional from Canada on 2007-07-10
Patient: 12 year old female
Adverse reactions / side effects: Personality Change, Affect Lability, Medication Error, Self-Injurious Ideation
Suspect drug(s):
Zantac (Ranitidine)
Adverse event in receiving Zantac (Ranitidine)
Reported by a consumer/non-health professional from Canada on 2007-07-10
Patient:
Adverse reactions / side effects: Intentional Overdose
Suspect drug(s):
Zantac (Ranitidine)
Adverse event in 90 year old male receiving Zantac (Ranitidine)
Reported by a individual with unspecified qualification from France on 2007-07-06
Patient: 90 year old male
Adverse reactions / side effects: Thrombocytopenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Keppra
Dosage: 1000 mg /d po
Administration route: Oral
End date: 2006-01-30
Zantac
Dosage: 150 mg /d po
Administration route: Oral
End date: 2006-01-30
Allopurinol
Dosage: 200 mg/d po
Administration route: Oral
End date: 2006-01-30
Paroxetine HCL
Dosage: 20 mg /d po
Administration route: Oral
End date: 2006-02-03
Other drugs received by patient: Irbesartan; Synacthene; Depakene; Zolpidem Tartrate
Adverse event in 76 year old male receiving Zantac (Ranitidine)
Reported by a physician from Japan on 2007-07-06
Patient: 76 year old male
Adverse reactions / side effects: Neutrophil Count Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Lipitor
Dosage: daily dose:10mg
Administration route: Oral
Aspirin
Dosage: daily dose:100mg-freq:day
Administration route: Oral
Start date: 2007-04-27
End date: 2007-06-10
Zantac
Dosage: daily dose:150mg-freq:day
Administration route: Oral
Start date: 2007-04-27
End date: 2007-06-10
Tenormin
Dosage: daily dose:50mg-freq:day
Administration route: Oral
Pletal
Administration route: Oral
Bepricor
Dosage: daily dose:100mg-freq:day
Administration route: Oral
Start date: 2007-04-27
End date: 2007-06-10
Sigmart
Dosage: daily dose:15mg-freq:day
Administration route: Oral
Start date: 2007-04-27
End date: 2007-06-10
Lendormin
Dosage: daily dose:.25mg-freq:day
Administration route: Oral
Warfarin Sodium
Dosage: daily dose:.5mg-freq:day
Administration route: Oral
Start date: 2007-04-27
End date: 2007-06-10
Adverse event in 2 month old female receiving Zantac (Ranitidine)
Reported by a consumer/non-health professional from United States on 2007-07-02
Patient: 2 month old female
Adverse reactions / side effects: Overdose, Developmental Delay, Convulsion
Adverse event resulted in: hospitalization
Suspect drug(s):
Zantac (Ranitidine)
Other drugs received by patient: NO Concurrent Medication
Adverse event in male receiving Zantac (Ranitidine)
Reported by a physician from Japan on 2007-07-02
Patient: male
Adverse reactions / side effects: Neutrophil Count Decreased
Suspect drug(s):
Lipitor
Dosage: daily dose:10mg
Administration route: Oral
Atenolol
Dosage: daily dose:50mg
Administration route: Oral
Indication: Cardiac Failure
Aspirin
Dosage: daily dose:100mg
Administration route: Oral
Start date: 2007-04-27
End date: 2007-06-10
Bepricor
Dosage: daily dose:100mg
Administration route: Oral
Start date: 2007-04-27
End date: 2007-06-10
Pletal
Administration route: Oral
Sigmart
Dosage: daily dose:15mg
Administration route: Oral
Start date: 2007-04-27
End date: 2007-06-10
Warfarin Sodium
Dosage: daily dose:.5mg
Administration route: Oral
Start date: 2007-04-27
End date: 2007-06-10
Zantac
Dosage: daily dose:150mg
Administration route: Oral
Start date: 2007-04-27
End date: 2007-06-10
Lendormin
Dosage: daily dose:.25mg-freq:frequency: prn
Administration route: Oral
Other drugs received by patient: Furosemide; Ambroxol Hydrochloride
Adverse event in 20 year old female receiving Zantac (Ranitidine)
Reported by a health professional (non-physician/pharmacist) from France on 2007-07-02
Patient: 20 year old female
Adverse reactions / side effects: Neutropenia, Normochromic Normocytic Anaemia
Adverse event resulted in: hospitalization
Suspect drug(s):
Effexor
Dosage: unknown
Administration route: Oral
End date: 2007-02-15
Rubozinc
Dosage: unknown
Administration route: Oral
Start date: 2007-02-23
End date: 2007-02-01
Zantac
Dosage: unknown
Administration route: Oral
Start date: 2007-01-01
End date: 2007-02-01
Other drugs received by patient: Atarax; Calcium Carbonate; Hept-A-MYL; Phocytan; Vitamin B1 and B6; Diffu K; Imodium; Tiorfan; Colecalciferol
Adverse event in male receiving Zantac (Ranitidine)
Reported by a physician from United States on 2007-06-28
Patient: male
Adverse reactions / side effects: Osteonecrosis
Adverse event resulted in: hospitalization
Suspect drug(s):
Enbrel
Indication: Rheumatoid Arthritis
Start date: 2004-01-01
Methotrexate
Start date: 2006-10-01
Mobic
Administration route: Oral
Start date: 2006-10-01
Vicodin ES
Start date: 2006-10-01
Zantac
Start date: 2006-10-01
Lorazepam
Start date: 2006-10-01
Adverse event in male receiving Zantac (Ranitidine)
Reported by a physician from Japan on 2007-06-28
Patient: male
Adverse reactions / side effects: Dyspnoea, Pulmonary Oedema, Myelodysplastic Syndrome, Pleural Effusion, Neutrophil Count Decreased
Suspect drug(s):
Tenormin
Administration route: Oral
Indication: Cardiac Failure
End date: 2007-06-10
Aspirin
Administration route: Oral
Start date: 2007-04-27
End date: 2007-06-10
Bepricor
Administration route: Oral
Start date: 2007-04-27
End date: 2007-06-10
Lendormin
Administration route: Oral
End date: 2007-06-10
Lipitor
Administration route: Oral
End date: 2007-06-10
Pletal
Administration route: Oral
Sigmart
Administration route: Oral
Start date: 2007-04-27
End date: 2007-06-10
Warfarin Potassium
Administration route: Oral
Start date: 2007-04-27
End date: 2007-06-10
Zantac
Administration route: Oral
Start date: 2007-04-27
End date: 2007-06-10
Other drugs received by patient: Furosemide; Ambroxol Hydrochloride
Adverse event in 77 year old female receiving Zantac (Ranitidine)
Reported by a physician from Japan on 2007-06-26
Patient: 77 year old female, weighing 45.0 kg (99.0 pounds)
Adverse reactions / side effects: Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Hypoaesthesia, Long QT Syndrome, Dysstasia, Convulsions Local, C-Reactive Protein Increased, Aspartate Aminotransferase Increased
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Zantac (Ranitidine)
Other drugs received by patient: Cyanocobalamin; Vitamedin; Mucosta
Adverse event in 27 year old female receiving Zantac (Ranitidine)
Reported by a physician from Mexico on 2007-06-22
Patient: 27 year old female
Adverse reactions / side effects: Dyspnoea, Pruritus, Urticaria, Dizziness, Pharmaceutical Product Complaint
Suspect drug(s):
Zantac (Ranitidine)
Adverse event in 55 year old male receiving Zantac (Ranitidine)
Reported by a physician from Japan on 2007-06-22
Patient: 55 year old male
Adverse reactions / side effects: Blood Bilirubin Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Zantac (Ranitidine)
Adverse event in 77 year old male receiving Zantac (Ranitidine)
Reported by a pharmacist from Japan on 2007-06-21
Patient: 77 year old male
Adverse reactions / side effects: Neutropenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Aspirin
Dosage: total daily dose: 100 mg unit dose: 100 mg
Administration route: Oral
End date: 2007-06-11
Zantac
Dosage: total daily dose: 150 mg unit dose: 150 mg
Administration route: Oral
End date: 2007-06-11
Lipitor
Dosage: total daily dose: 10 mg unit dose: 10 mg
Administration route: Oral
End date: 2007-06-11
Tenormin
Dosage: total daily dose: 50 mg unit dose: 50 mg
Administration route: Oral
End date: 2007-06-11
Pletal
Administration route: Oral
End date: 2007-06-11
Bepricor
Administration route: Oral
End date: 2007-06-11
Sigmart
Administration route: Oral
End date: 2007-06-11
Lendormin
Administration route: Oral
Indication: Insomnia
End date: 2007-06-11
Warfarin Potassium
Administration route: Oral
End date: 2007-06-11
Other drugs received by patient: Lasix; Mucosolvan
Adverse event in 58 year old male receiving Zantac (Ranitidine)
Reported by a consumer/non-health professional from France on 2007-06-20
Patient: 58 year old male, weighing 78.0 kg (171.6 pounds)
Adverse reactions / side effects: Bone Marrow Failure
Adverse event resulted in: life threatening event
Suspect drug(s):
Zantac
Start date: 2006-09-15
End date: 2006-09-15
Trandate
Start date: 2006-09-07
End date: 2006-09-17
Ciflox
Dosage: 750mg per day
Indication: Prostatitis
Start date: 2006-08-25
End date: 2006-09-14
Omeprazole
Start date: 2006-07-05
End date: 2006-09-12
Vfend
Start date: 2006-07-27
End date: 2006-09-11
Valganciclovir HCL
Start date: 2006-08-16
End date: 2006-09-11
Page 1 Next >>
|
